NCT04771156PHASE4Recruiting

Ketorolac in Palatoplasty

The University of Texas Health Science Center, Houston

Start Date

9/17/2021

Completion Date

4/1/2027

Summary

The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: -Patient with Cleft palate (Complete and incomplete), with or without cleft lip, unilateral or bilateral Exclusion Criteria: * Syndromic Cleft Palate patients * Previous palatoplasty * Major unrepaired cardiac malformation * History of GI complications (GI Bleed, Gastric Ulceration) * History of Renal disorder * History of coagulopathy (As contraindication to NSAID use) * Feeding tube dependency * Patients whose parents refuse to consent to randomization

Interventions

DRUG

Ketorolac

DRUG

Placebo

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cleft Lip and Palate

Locations

The University of Texas Health Science Center at Houston

Houston, Texas 77030

United States